孕期糖尿病女性的饮食摄入量和遵守建议
Lotta Saros1, Tero Vahlberg2, Outi Pellonperä3
1Integrative Physiology and Pharmacology Unit, Institute of Biomedicine, University of Turku, 20520, Turku, Finland. loevpa@utu.fi.
European journal of clinical nutrition
|March 19, 2025
概括
患有妊娠糖尿病 (GDM) 的女性对蛋白质和纤维摄入量建议的坚持不佳. 然而,整体上,良好的饮食质量与GDM患者更好地控制葡萄糖代谢有关.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 营养科学 营养科学
背景情况:
- 孕期糖尿病 (GDM) 管理主要依赖于生活方式干预.
- 调查GDM的饮食坚持对于优化血糖控制至关重要.
- 了解饮食模式可以为孕妇提供有针对性的营养指导.
研究的目的:
- 评估GDM妇女是否遵守特定的饮食建议.
- 为了比较GDM和没有GDM的女性之间的饮食坚持和质量.
- 评估饮食质量对患有GDM的女性血糖控制的影响.
主要方法:
- 招募超重/肥胖的孕妇 (n=349) 的情况.
- 使用2小时口服葡萄糖耐受性测试来诊断GDM.
- 饮食评估包括饮食质量指数和3天食物日记.
- 在怀孕晚期血液样本中分析葡萄糖和胰岛素度.
主要成果:
- 患有GDM的女性 (n=98) 经常遵循更健康的饮食模式 (62.2%) 比对照组 (49.0%).
- 在GDM患者中,蛋白质 (16.3%) 和纤维 (4.1%) 的坚持率较低,但糖糖 (69.4%) 的坚持率较高.
- 良好的饮食质量与GDM妇女的胰岛素和HOMA2-IR值较低相关.
结论:
- 在患有GDM的女性中,遵守蛋白质和纤维建议是不充分的.
- 整体饮食质量与改善葡萄糖代谢控制有关.
- 饮食咨询应专注于改善对GDM管理的关键营养建议的遵守.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes
837
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
837
Insulin: Dosing Regimen and Adverse Effects
134
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
134
Oral Hypoglycemic Agents: Biguanides and Glitazones
148
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
148
Diabetes: Symptoms, Diagnosis, and Complications
494
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
494
Diabetes: Management and Pharmacotherapy
216
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
216


